Full Press Release Details
Viking Therapeutics to Present at H.C. Wainwright Global Investment Conference.
VKTX
Viking Therapeutics to Present at H.C. Wainwright Global Investment Conference
Key Takeaway: Viking Therapeutics to Present at H.C. Wainwright Global Investment Conference
Price reaction · baseline $2.33 (2022-05-13 close) · clean, no other VKTX news in the window
day 0 close
+0.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss